Prediction and principle discovery of drug combination based on multimodal friendship features

He-Gang Chen,XIONGHUI ZHOU
DOI: https://doi.org/10.1101/2024.08.28.610203
2024-08-30
Abstract:Combination therapy, which can improve therapeutic efficacy and reduce side effects, plays an important role in the treatment of multiple complex diseases. Yet, the design principles of molecular combinations remain unclear. In addition, the huge search space of candidate drug combinations and the numerous heterogeneous data has brought us a big challenge. Here, we proposed a Friendship based Method (FSM), which integrates diverse drug-to-drug information to predict drug combinations for specific diseases. By quantifying the friendship-based relationship between drugs, we found that there is a moderate similarity between the drugs of effective drug combinations in a high-dimensional, heterogeneous feature space. Following this discovery, FSM applied a two-step strategy to predict clinically efficacious drug combinations for specific diseases. First, our method employs the friendship features to evaluate whether each drug is combinable. Then, the synergistic potential of combinable drugs was further evaluated. FSM was validated on two types of disease. The results show that FSM achieves substantial performance improvement over other state-of-the-art methods and tends to have low toxicity. These results indicate that our model could potentially offer a generic, powerful strategy to identify efficacious combination therapies in the vast search space.
Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: how to effectively predict clinically effective drug combinations for specific diseases in the huge candidate drug combination space and reveal the principles behind these combinations. Specifically, the paper points out that traditional single - drug therapies have limited effectiveness for complex diseases such as cancer and cardiovascular diseases, while combination therapies can improve efficacy and reduce side effects, but currently the design principles for molecular combinations are still unclear. In addition, the large number of candidate drug combinations and the diversity of heterogeneous data pose great challenges to the identification of effective combinations. Therefore, the paper proposes a method based on "friendship" features (FSM), which predicts drug combinations for specific diseases by integrating different types of drug - drug information, aiming to overcome the limitations of existing methods, such as single data type, ignoring relationships between drugs, and insufficient pre - screening ability. FSM discovers effective drug combination patterns in the high - dimensional heterogeneous feature space by quantifying the "friendship" relationships between drugs and adopts a two - step strategy for prediction: first, evaluate whether each drug can be combined, and then further evaluate the synergy potential of combinable drugs. The research results show that FSM is significantly superior to other state - of - the - art methods in performance, and the predicted drug combinations have lower toxicity, showing its potential as a powerful tool for identifying effective combination therapies.